Qube Research & Technologies LTD Zai Lab LTD Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $353,895 - $614,869	15,884 New	15,884 $487,000
Q4 2021 Feb 01, 2022	SELL	$54.9 - $105.21 $802,528 - $1.54 Million	-14,618 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $1.53 Million - $2.61 Million	14,618 New	14,618 $1.54 Million
Q2 2021 Aug 13, 2021	SELL	$125.11 - $180.0 $934,196 - $1.34 Million	-7,467 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$126.27 - $191.71 $942,858 - $1.43 Million	7,467 New	7,467 $996,000
Q4 2020 Feb 16, 2021	SELL	$81.94 - $135.34 $472,793 - $780,911	-5,770 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$73.3 - $89.48 $2.13 Million - $2.6 Million	-29,048 Reduced 83.43%	5,770 $480,000
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $1.07 Million - $1.81 Million	21,910 Added 169.74%	34,818 $2.86 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $504,702 - $811,913	12,908 New	12,908 $665,000

123

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.55B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.